Oritinib
Oritinib is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q), EGFR (L858R/T790M), EGFR (d746-750), EGFR (d746-750/T790M), respectively. Oritinib can be used in studies about the treatment of non-small cell lung cancer.
Product Specifications
CAS Number
2035089-28-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
539.67
Molecular Formula
C31H37N7O2
Notes
Research use only, not for human use.
Receptor
——
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1162997-01 0.02 mg (E-Coli)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details 
MBS1162997-02 0.02 mg (Yeast)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details MBS1162997-03 0.1 mg (E-Coli)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details MBS1162997-04 0.1 mg (Yeast)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details 
MBS1162997-05 0.02 mg (Baculovirus)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details MBS1162997-06 0.02 mg (Mammalian-Cell)
Recombinant Bacillus cereus subsp. cytotoxis Phosphoglycerate kinase (pgk)
Ask
View Details